Call Off Contract for Referred Biochemistry and Haematology Tests

CPV: Pathology services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

10 Feb 2026, 15:03 GMT

Last source update

16 Mar 2026, 13:57 GMT

Authority reference

C381239

FTS notice number

2026/S 000-023524

Classification (CPV)

Pathology services

Delivery area

Yorkshire & Humber (UKE41)

Official registry OCID

ocds-h6vhtk-064cdd Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 20/02/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 20/02/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.’<br/><br/>Award decision-makers;<br/>Afruj Ruf<br/>Rebecca Parish<br/><br/>“Based on the Authorities assessment and PSR decision making process (taking into account key criteria; quality, value, integration, inequalities and access), ILS LLP intends to award a contract to an existing provider following Direct Award Process C under the Provider Selection Regime (PSR).<br/><br/>The authority is proposing a new contract to replace the existing contract at the end of its term and the proposed contracting arrangements are not changing considerably.<br/><br/>ILS LLP is of the view that the existing provider is satisfying the contract to a sufficient standard and will likely satisfy the proposed contract to a sufficient standard.<br/><br/>Direct Award Processes A (only one provider can provide the services) and B (unrestricted patient choice) do not apply and a competitive process is unlikely to add value for patients, taxpayers, or the population.<br/><br/><br/>The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 20/02/2026 (8 working days from publication) via email to: [email protected]<br/><br/>This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. The contract will not be awarded until the period has ended and any representations have been considered.<br/><br/>No conflicts of interest were identified during the procurement process.<br/><br/>No subcontracting is expected.

• North West London PathologyAwarded supplier London, London, Yorkshire & Humber, W12 0HS

No document links were published on the notice.